A Systematic Study of <i>C</i>-Glucoside Trisphosphates as <i>myo</i>-Inositol Trisphosphate Receptor Ligands. Synthesis of β-<i>C</i>-Glucoside Trisphosphates Based on the Conformational Restriction Strategy
作者:Masaru Terauchi、Hiroshi Abe、Stephen C. Tovey、Skarlatos G. Dedos、Colin W. Taylor、Michael Paul、Melanie Trusselle、Barry V. L. Potter、Akira Matsuda、Satoshi Shuto
DOI:10.1021/jm051039n
日期:2006.3.1
Beta-C-glucoside trisphosphates having a C2 side chain (3,7-anhydro-2-deoxy-D-glycero-D-gulo-octitol 1,5,6-trisphosphate, 11) and a C3 side chain (4,8-anhydro-2,3-dideoxy-D-glycero-D-gulo-nonanitol 1,6,7-trisphosphate, 12) were designed as structurally simplified analogues of a potent D-myo-inositol 1,4,5-trisphosphate (IP3) receptor ligand, adenophostin A. Construction of the beta-C-glucosidic structure
具有C2侧链(3,7-脱水-2-脱氧-D-甘油-D-邻-辛醇1,5,6-三三磷酸11)和C3侧链(4,8)的β-C-葡萄糖苷三磷酸酯-脱水-2,3-二脱氧-D-甘油-D-古洛诺壬醇1,6,7-三磷酸酯(12)被设计为强力D-肌醇1,4,5-三磷酸酯的结构简化类似物( IP3)受体配体,腺苷A。构建β-C-糖苷结构的关键,是通过两种基于构象限制策略的不同方法实现的:(1)使用临时连接的硅系链进行自由基环化(2)具有异头烯丙基取代基的糖脂醇的硅烷还原。使用这些方法,成功地合成了目标β-C-糖苷三磷酸酯11和12。在一系列C-葡萄糖苷三磷酸酯上建立了结构活性关系,包括先前合成的相关化合物,这些化合物是腺磷素A的C-糖苷类似物3,其尿嘧啶同类物5,α-C-葡萄糖苷三磷酸酯7-9具有C1,C2或C3侧链,以及具有C1,C2或C3侧链的β-C-葡糖苷三磷酸酯10-12。腺苷A及其类似物的O-糖苷键被化